Equities

NEOD

SE0021615655

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm Other stock markets 10:36:05 2024-04-29 am EDT			5-day change	1st Jan Change
0.95 ^SEK	+3.94%		+1.06%	-56.82%

Apr. 15	Air Astana Partner with Italy-based Neos	MT
Mar. 22	NeoDynamics AB Announces Appointment of Matilda Salén as Its New Chief Executive Officer	CI

Anna Eriksrud Announces Desire to Retire as CEO of NeoDynamics AB

February 29, 2024 at 07:00 am EST

NeoDynamics AB (publ) announces that Anna Eriksrud announces desire to retire as CEO of the company. Anna Eriksrud, CEO joined NeoDynamics in 2016 and led the company from the start-up phase through to FDA clearance of NeoNavia ® and commercial launch in Europe and the US.

Latest news about NEOS AB

Air Astana Partner with Italy-based Neos	Apr. 15	MT
NeoDynamics AB Announces Appointment of Matilda Salén as Its New Chief Executive Officer	Mar. 22	CI
Anna Eriksrud Announces Desire to Retire as CEO of NeoDynamics AB	Feb. 29	CI
NeoDynamics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 16	CI
NeoDynamics AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 16	CI
NeoDynamics AB Announces CFO Aaron Wong to Leave by End of May 2024	Dec. 13	CI
Neodynamics Launches Device Registry in Germany, Cost-Effective Collection of Real-World Data	Dec. 11	CI
NeoDynamics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
NeoDynamics Announces Cost Reduction Plan	Nov. 13	CI
NeoDynamics AB Receives New Order from Western Rhineland-Palatinate Hospital in Germany	23-10-18	CI
NeoDynamics Soars 42% Amid First US Order for Invasive Biopsy System NeoNavia	23-08-09	MT
NeoDynamics AB Receives First Commercial Order from Top University Hospital	23-08-09	CI
NeoDynamics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-31	CI
Neodynamics AB Presents Results of Pulse Study At the Annual Congress of the German Society of Senology, Munich	23-07-10	CI
NeoDynamics Plans SEK72 Million Rights Issue to Fund Commercialization, Marketing Operations	23-06-23	MT
NeoDynamics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
NeoDynamics AB Presents Final Data Set from NeoDynamics' Pulse Study Presented at the SBI Breast Imaging Symposium	23-05-05	CI
Sweden’s NeoDynamics Launches New Biopsy Technology in US	23-04-27	MT
Neodynamics, Inc. Announces U.S. Availability of Neonavia, the First and Only Pulse Biopsy Technology, Fda-Cleared in Breast and Axillary Lymph Node Biopsies	23-04-27	CI
Neodynamics AB Announces Delivery of Corepulse Needles to 23 Hospitals	23-04-03	CI
NeoDynamics Receives Chinese Patent for NeoNavia FlexiPulse	23-03-06	MT
NeoDynamics AB Receives Chinese Patent for FlexiPulse Needle Design	23-03-06	CI
NeoDynamics AB announced that it expects to receive SEK 14 million in funding from Gryningskust Holding AB	23-02-28	CI
NeoDynamics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-17	CI
NeoDynamics Announces Changes to Board of Directors	23-02-15	CI

Chart NEOS AB

Duration

Period

More charts

Company Profile

NeoDynamics AB (publ) is a Sweden-based company engaged in the medical industry. The Company focuses on developing and commercializing products for breast cancer screening, imaging, and breast cancer treatments. The Companyâs product NeoNavia, enables a pulse biopsy system for ultrasound guided tissue sampling. It consists of a base unit, a handheld driver and three different types of biopsy needles. Each needle type is driven by the pulse technology providing a more controlled needle insertion and precise placement of the needle in the tumour whilst enabling tissue samples from both breasts and lymph nodes. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at clinics in United Kingdom, Germany, and Sweden.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-06 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for NEOS AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
NEOS AB	-56.82%	2.72M
SARTORIUS AG	-11.79%	19.08B
QUIDELORTHO CORPORATION	-44.41%	2.65B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+18.15%	1.87B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.12%	1.61B
BIOTAGE AB	+26.03%	1.21B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-10.69%	1.02B
CONTEC MEDICAL SYSTEMS CO.,LTD	-20.89%	905M
REVENIO GROUP OYJ	-4.34%	716M
VAREX IMAGING CORPORATION	-17.51%	682M

Medical Diagnostic & Testing Equipment